On November 26, 2018 Heat Biologics, Inc. (NASDAQ: HTBX), a biopharmaceutical company developing therapies designed to activate a patient’s immune system against cancer, reported that it has been invited to participate in a panel presentation, entitled Gene &Cell Therapy: The Next Wave of Precision Medicine Panel, at 12:30 pm HKT on Tuesday, November 27th at the Goldman Sachs Asia Pacific Healthcare Forum in Hong Kong. John Prendergast, Ph.D., Heat’s Lead Director, will be presenting (Press release, Heat Biologics, NOV 26, 2018, View Source [SID1234531615]).

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The event will feature leading public and private healthcare companies with ongoing or planned activities in China. The forum is by invitation only.